Search details
1.
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Lancet
; 398(10297): 314-324, 2021 07 24.
Article
in English
| MEDLINE | ID: mdl-34175021
2.
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.
N Engl J Med
; 367(18): 1694-703, 2012 11 01.
Article
in English
| MEDLINE | ID: mdl-23020132
3.
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.
J Clin Oncol
; 41(6): 1265-1274, 2023 02 20.
Article
in English
| MEDLINE | ID: mdl-35658469
4.
Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers.
Br J Clin Pharmacol
; 72(2): 321-9, 2011 Aug.
Article
in English
| MEDLINE | ID: mdl-21434975
5.
JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes-Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies.
JTO Clin Res Rep
; 2(2): 100103, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-34589981
6.
Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.
J Clin Invest
; 116(8): 2218-25, 2006 Aug.
Article
in English
| MEDLINE | ID: mdl-16878172
7.
Relative bioavailability of pediatric oral solution and tablet formulations of trametinib in adult patients with solid tumors.
Clin Pharmacol Drug Dev
; 4(4): 287-94, 2015 07.
Article
in English
| MEDLINE | ID: mdl-27136909
8.
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma.
Cancer Chemother Pharmacol
; 75(1): 183-9, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25417902
9.
Phase I study of GSK461364, a specific and competitive Polo-like kinase 1 inhibitor, in patients with advanced solid malignancies.
Clin Cancer Res
; 17(10): 3420-30, 2011 May 15.
Article
in English
| MEDLINE | ID: mdl-21459796
10.
Targeted proteomic profiling of renal Na(+) transporter and channel abundances in angiotensin II type 1a receptor knockout mice.
Hypertension
; 39(2 Pt 2): 470-3, 2002 Feb.
Article
in English
| MEDLINE | ID: mdl-11882592
Results
1 -
10
de 10
1
Next >
>>